ly 300164 has been researched along with Brain Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blecic, S; De Witte, O; Lefranc, F; Rynkowski, M | 1 |
| Ishiuchi, S | 1 |
| Batchelor, T; Chamberlain, M; Desideri, S; Fine, HA; Fisher, J; Grossman, SA; Mikkelsen, T; Piantadosi, S; Ye, X | 1 |
| Albert, PS; Butman, JA; Duic, JP; Fine, HA; Iwamoto, FM; Kim, L; Kreisl, TN | 1 |
| Desideri, S; Fisher, J; Grossman, SA; Nabors, LB; Piantadosi, S; Rosenfeld, M; Ye, X | 1 |
| de Groot, J; Sontheimer, H | 1 |
3 review(s) available for ly 300164 and Brain Neoplasms
| Article | Year |
|---|---|
[Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications].
Topics: Benzodiazepines; Brain Neoplasms; Cell Death; Cell Movement; Cell Proliferation; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glioma; Glutamic Acid; Humans; Memantine; Neoplasm Invasiveness; Neuroglia; Neurons; Receptors, AMPA; Receptors, Glutamate; Seizures; Sulfasalazine | 2013 |
[New roles of glutamate receptors in glias and gliomas].
Topics: Adenosine Deaminase; Animals; Benzodiazepines; Brain Neoplasms; Calcium; Cerebellum; Excitatory Amino Acid Antagonists; Glioma; Humans; Neoplasm Invasiveness; Neuroglia; Oncogene Protein v-akt; Phosphorylation; Receptors, AMPA; Receptors, Glutamate; RNA Editing; RNA-Binding Proteins | 2009 |
Glutamate and the biology of gliomas.
Topics: Animals; Benzodiazepines; Brain; Brain Neoplasms; Glioma; Glutamic Acid; Humans; Models, Biological; Receptors, AMPA; Signal Transduction | 2011 |
2 trial(s) available for ly 300164 and Brain Neoplasms
| Article | Year |
|---|---|
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Brain Neoplasms; Cranial Irradiation; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Excitatory Amino Acid Antagonists; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Proportional Hazards Models; Radiotherapy, Adjuvant; Receptors, AMPA; Risk Assessment; Temozolomide; Time Factors; Treatment Outcome; Tumor Suppressor Proteins; United States | 2009 |
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Benzodiazepines; Brain Neoplasms; Disease-Free Survival; Drug Evaluation; Female; Glioma; Humans; Male; Middle Aged; Receptors, AMPA | 2010 |
1 other study(ies) available for ly 300164 and Brain Neoplasms
| Article | Year |
|---|---|
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Benzodiazepines; Biomedical Research; Brain Neoplasms; Carboxymethylcellulose Sodium; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Drug Therapy, Combination; Female; Glioblastoma; Humans; Interferon Inducers; Male; Middle Aged; Poly I-C; Polylysine; Receptors, AMPA; Snake Venoms; Survival Rate; Temozolomide; Treatment Outcome; United States; Young Adult | 2010 |